Jean-Paul Garraud

Ask VT AI
View News Summary
  • Crocs shares plunge due to declining Q3 sales, tariff impact, and shifting consumer behavior, leading the company to adjust its strategy to protect brand health and profitability.
  • Decades after 9/11, advanced DNA testing identifies three more victims, providing closure to families.
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on the back of its HIV portfolio and new drug launches.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Crocs shares plunge due to declining Q3 sales, tariff impact, and shifting consumer behavior, leading the company to adjust its strategy to protect brand health and profitability.
  • Decades after 9/11, advanced DNA testing identifies three more victims, providing closure to families.
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on the back of its HIV portfolio and new drug launches.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Jean-Paul Garraud